Kazuo Tokuda

Pharmaceutical Science Dept.
Chugai Pharmaceutical Co., Ltd.

Presentation(s):

• VPB0170 - Correlation of Factor VIII Activity Measured by One-Stage Clotting and Chromogenic Substrate Assays in a Phase III Study of Emicizumab Prophylaxis for Acquired Hemophilia A (AGEHA)

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM